Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, D'Angelo E, Giaj Levra N, Fozza A, Taraborrelli M, Piperno G, Vanoni V, Sepulcri M, Trovò M, Nardone V, Lattanzi E, Bou Selman S, Bertolini F, Franceschini D, Agustoni F, Jereczek-Fossa BA, Magrini SM, Livi L, Lohr F, Filippi AR. Bruni A, et al. Among authors: fozza a. Front Oncol. 2021 Sep 28;11:744956. doi: 10.3389/fonc.2021.744956. eCollection 2021. Front Oncol. 2021. PMID: 34650927 Free PMC article.
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.
Rovea P, Fozza A, Franco P, De Colle C, Cannizzaro A, Di Dio A, De Monte F, Rosmino C, Filippi AR, Ragona R, Ricardi U. Rovea P, et al. Among authors: fozza a. Clin Breast Cancer. 2015 Aug;15(4):270-6. doi: 10.1016/j.clbc.2014.12.011. Epub 2015 Jan 7. Clin Breast Cancer. 2015. PMID: 25666079
Radiotherapy in patients with HIV: current issues and review of the literature.
Alongi F, Giaj-Levra N, Sciascia S, Fozza A, Fersino S, Fiorentino A, Mazzola R, Ricchetti F, Buglione M, Buonfrate D, Roccatello D, Ricardi U, Bisoffi Z. Alongi F, et al. Among authors: fozza a. Lancet Oncol. 2017 Jul;18(7):e379-e393. doi: 10.1016/S1470-2045(17)30440-0. Lancet Oncol. 2017. PMID: 28677574 Free article. Review.
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)-Lung Working Group.
Parisi G, Mazzola R, Ciammella P, Timon G, Fozza A, Franceschini D, Navarria F, Bruni A, Perna M, Giaj-Levra N, Alongi F, Scotti V, Trovo M. Parisi G, et al. Among authors: fozza a. Radiol Med. 2019 Feb;124(2):136-144. doi: 10.1007/s11547-018-0950-z. Epub 2018 Oct 27. Radiol Med. 2019. PMID: 30368721
Current radiotherapy techniques in NSCLC: challenges and potential solutions.
Giaj-Levra N, Borghetti P, Bruni A, Ciammella P, Cuccia F, Fozza A, Franceschini D, Scotti V, Vagge S, Alongi F. Giaj-Levra N, et al. Among authors: fozza a. Expert Rev Anticancer Ther. 2020 May;20(5):387-402. doi: 10.1080/14737140.2020.1760094. Epub 2020 May 13. Expert Rev Anticancer Ther. 2020. PMID: 32321330 Review.
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC.
Perna M, Scotti V, Ciammella P, Borghetti P, D'angelo E, Levra NG, Fozza A, Mariotti M, Salvestrini V, Bertolini F, Vagge S, Taraborrelli M, Falcinelli L, Taddeo A, Rossi R, Costantino G, Frassinelli L, Filippi AR, Greco C, Franceschini D, Genovesi D, Lohr F, Magrini SM, Alongi F, Livi L, Bruni A. Perna M, et al. Among authors: fozza a. Clin Lung Cancer. 2021 Sep;22(5):e767-e773. doi: 10.1016/j.cllc.2021.02.005. Epub 2021 Feb 16. Clin Lung Cancer. 2021. PMID: 33766477
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?
Fozza A, Giaj-Levra N, De Rose F, Ippolito E, Silipigni S, Meduri B, Fiorentino A, Gregucci F, Marino L, Di Grazia A, Cucciarelli F, Borghesi S, De Santis MC, Ciabattoni A. Fozza A, et al. Expert Rev Anticancer Ther. 2021 Aug;21(8):827-840. doi: 10.1080/14737140.2021.1917390. Epub 2021 Apr 25. Expert Rev Anticancer Ther. 2021. PMID: 33852379 Review.
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, D'Angelo E, Giaj Levra N, Fozza A, Taraborrelli M, Piperno G, Vanoni V, Sepulcri M, Trovò M, Nardone V, Lattanzi E, Bou Selman S, Bertolini F, Franceschini D, Agustoni F, Jereczek-Fossa BA, Magrini SM, Livi L, Lohr F, Filippi AR. Bruni A, et al. Among authors: fozza a. Front Oncol. 2021 Nov 16;11:802949. doi: 10.3389/fonc.2021.802949. eCollection 2021. Front Oncol. 2021. PMID: 34869046 Free PMC article.
26 results